SCHEMBL8106763

SCHEMBL8106763

CCc1[c]ccc(F)c1CCc1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.37
TP53 P04637 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
ALDH1A1 P00352 1/20 0.36
TAAR1 Q96RJ0 3/20 0.34
CYP2A6 P11509 1/20 0.34
HTR2A P28223 1/20 0.34
LOXL2 Q9Y4K0 1/20 0.34
BCL2 P10415 1/20 0.33
BCL2L1 Q07817 1/20 0.33
MCL1 Q07820 1/20 0.33
BCL2A1 Q16548 1/20 0.33
KCNH2 Q12809 2/20 0.33
MAOA P21397 3/20 0.32
MAOB P27338 2/20 0.32
CHRM2 P08172 1/20 0.32
HTR1A P08908 1/20 0.32
ADRA2A P08913 1/20 0.32
CHRM1 P11229 1/20 0.32
DRD1 P21728 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2139795 0.79
SCHEMBL8106395 0.73 CALM1 (0.39) KDM4ESMN1; SMN2ALDH1A1TAAR1CYP2A6
SCHEMBL8106410 0.72
SCHEMBL22050353 0.70 KDM4E (0.52) KDM4ESMN1; SMN2ALDH1A1TAAR1CYP2A6
SCHEMBL18301290 0.70 TP53 (0.35) TP53ALDH1A1KCNH2MAOAMAOB
SCHEMBL2137371 0.69 NPC1 (0.32) SMN1; SMN2
SCHEMBL576902 0.69
SCHEMBL455831 0.69
SCHEMBL5150284 0.68 HTT (0.41) TP53ALDH1A1KCNH2MAOAMAOB
SCHEMBL8939781 0.67 CALM1 (0.41) KDM4ESMN1; SMN2ALDH1A1TAAR1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6133276-A A LIGAND INHIBITOR OF A CRF/CRF-BINDING PROTEIN COMPLEX TO EFFECT INCREASED LEVELS OF CRF; 2,4-DIOXO- OR 2-THIOCARBONYL-4-OXO-5-(HYDROCARBYL(THIO)CARBONYLAMINOMETHYL)-6-HYDROXY-HEXA-HEXAHYDROPYRIMIDINES; ALZHEIMER'S, OBESITY; LOW SIDE EFFECTS NEUROCRINE BIOSCIENCES, INC. (US) 2000-10-17 US disclosed